Suchergebnisse - (Person:"Shen, Han")

PubPharm (948)

81

Clinical Outcomes by Consolidation of Bone Marrow Stem Cell Therapy and Coronary Artery Bypass Graft in Patients With Heart Failure With Reduced Ejection Fraction : A Meta-analysis

enthalten in: Cell transplantation | 2023

von Jiang, Y. | Yang, Z. | Shao, L. | +7

82

CRISPR-Cas and catalytic hairpin assembly technology for target-initiated amplification detection of pancreatic cancer specific tsRNAs

enthalten in: Frontiers in bioengineering and biotechnology | 2023

von Wu, J. | Xu, H. | Hu, F. | +8

83

Fungal gut microbiota dysbiosis in systemic lupus erythematosus

enthalten in: Frontiers in microbiology | 2023

von Yang, P. | Xu, R. | Chen, F. | +7

84

Genome-wide identification and oxacillinase OXA distribution characteristics of Acinetobacter spp. based on a global database

enthalten in: Frontiers in microbiology | 2023

von Li, J. | Li, Y. | Cao, X. | +6

85

Association Between rs2200733 Polymorphism of PITX2 Gene and the Risk of Atrial Fibrillation

in: Anatolian Journal of Cardiology | 2023

von Yin Shen Han | Abass Mahamoud Ahmed | Zhu Chao | +2

86

Gradient Graphdiyne Induced Copper and Oxygen Vacancies in Cu0.95 V2 O5 Anodes for Fast‐Charging Lithium‐Ion Batteries

enthalten in: Angewandte Chemie | 2023

von Wang, F. | An, J. | Shen, H. | +3

87

Gradient Graphdiyne Induced Copper and Oxygen Vacancies in Cu0.95 V2 O5 Anodes for Fast‐Charging Lithium‐Ion Batteries

enthalten in: Angewandte Chemie International Edition | 2023

von Wang, F. | An, J. | Shen, H. | +3

88

Role of adenosine A2a receptor in cancers and autoimmune diseases

enthalten in: Immunity, Inflammation and Disease | 2023

von Ye, H. | Zhao, J. | Xu, X. | +3

89

lncRNA NEAT1 mediates LPS‐induced pyroptosis of BEAS‐2B cells via targeting miR‐26a‐5p/ ROCK1 axis

enthalten in: The Kaohsiung Journal of Medical Sciences | 2023

von Fan, X. | Ma, Z. | Tang, L. | +3

90

Cancer‐associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD‐1 inhibitors and antiangiogenic agents in hepatocellular carcinoma

enthalten in: Cancer | 2023

von Chen, Q. | Wang, X. | Zheng, Y. | +9